Mesoblast Ltd News

Mesoblast Ltd: Corporate Presentation

Jun 2 19:22 ET

Mesoblast Ltd: Entitlement Offer and Placement Investor Presentation

Dec 3, 2023 20:44 ET

Mesoblast Ltd: Amended Constitution

Nov 29, 2023 01:04 ET

Mesoblast Ltd: Results of Meeting

Nov 28, 2023 01:25 ET

Mesoblast Ltd: CEO Presentation to 2023 Annual General Meeting

Nov 27, 2023 19:57 ET

Mesoblast Ltd: Mesoblast Corporate Presentation

Nov 14, 2023 17:55 ET

Mesoblast Ltd: Notice of Annual General Meeting and Proxy Form

Oct 29, 2023 17:58 ET

Mesoblast Ltd: Third Quarter Results Presentation

May 25, 2023 18:26 ET

Mesoblast Ltd: Biotech Showcase 2023 Presentation in San Francisco

Jan 9, 2023 18:08 ET

Mesoblast Ltd: Amended Constitution

Nov 24, 2022 00:45 ET

Mesoblast Ltd: Results of Meeting

Nov 23, 2022 00:07 ET

Mesoblast Ltd: CEO First Quarter Results and 2022 AGM Presentation

Nov 22, 2022 16:45 ET

Mesoblast Ltd: Removal of Amendment to Constitution About Virtual Meetings

Nov 14, 2022 17:29 ET

Mesoblast Ltd: Notice of Annual General Meeting and Proxy Form

Oct 23, 2022 19:07 ET

Mesoblast Ltd: Director Appointment

Aug 17, 2022 20:01 ET

Mesoblast Ltd: Chronic Low Back Pain KOL Event Presentation

Jun 20, 2022 19:54 ET

Mesoblast Ltd: Third Quarter Results Presentation

May 31, 2022 19:34 ET

Mesoblast Ltd: Company Secretary Appointment

Apr 6, 2022 03:01 ET

Mesoblast Ltd: Director Appointment

Mar 23, 2022 19:04 ET

Mesoblast Ltd: Biotech Showcase 2022 Presentation

Jan 11, 2022 17:56 ET